Paper571963
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.
Farrell PJ and 2 others. Nature, 1979. Cited by 277 papers, by iCite.
Cite this record
ConductScience Library. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Papers, record 571963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/571963
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Ehrlich Tumor | Major topic |
| Interferons | Major topic |
| Neoplasm Proteins | Major topic |
| RNA, Messenger | Major topic |
| Animals | |
| Cell-Free System | |
| Isoelectric Point | |
| Molecular Weight | |
| RNA, Neoplasm |
Source PubMed
Cited by142
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42884081 | ISG15 Is a Key Multidirectional Regulator of Cytosolic RNA- and DNA-Sensing Pathways and Type I Interferon Feedback Loops. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884081 | PubMed |
| 42652131 | RNF213 in Panvascular Disease: A Molecular Hub Linking Genetic Susceptibility to Systemic Vasculopathy. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652131 | PubMed |
| 42442365 | Understanding protein ISGylation, a multifaceted posttranslational modification. | Cell Chem Biol | 2026 | https://conductscience.org/library/papers/42442365 | PubMed |
| 42303907 | SEMA6A inhibits tumor progression and boosts anti-tumor immunity via blocking the ISG15/TGFβ axis in colorectal cancer. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42303907 | PubMed |
| 42111249 | The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer's disease. | Mol Neurodegener Adv | 2026 | https://conductscience.org/library/papers/42111249 | PubMed |
| 42058221 | When ISG15 is involved in inflammation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42058221 | PubMed |
| 42023152 | ISGylation is disrupted by UBA7 gene variants identified in individuals with neurodevelopmental disorder phenotypes. | iScience | 2026 | https://conductscience.org/library/papers/42023152 | PubMed |
| 41512080 | The OAS-RNase L pathway: Insights from experiments of nature. | Sci Immunol | 2026 | https://conductscience.org/library/papers/41512080 | PubMed |
| 41476985 | Temporal modulation of gene expression in a controlled Schistosoma mansoni human infection model. | Front Immunol | 2025 | https://conductscience.org/library/papers/41476985 | PubMed |
| 40904511 | Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis. | Front Oncol | 2025 | https://conductscience.org/library/papers/40904511 | PubMed |
| 40896734 | Houttuynia cordata triggers type I interferon signaling to promote host defense against Acinetobacter baumannii infection via mTORC1 activation. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40896734 | PubMed |
| 40719862 | ISG-15, beyond its functions in the cell: a mini review. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40719862 | PubMed |
| 40410283 | Spermidine reduces ISGylation and enhances ISG15-USP18 interaction. | Sci Rep | 2025 | https://conductscience.org/library/papers/40410283 | PubMed |
| 40353372 | Interferon-induced protein ISG15 in the central nervous system, quo vadis? | FEBS Lett | 2025 | https://conductscience.org/library/papers/40353372 | PubMed |
| 40103488 | ISGylation: is our genome yearning for such a modification? | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/40103488 | PubMed |
| 39931755 | ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/39931755 | PubMed |
| 38891017 | The Effects of Smoking on Telomere Length, Induction of Oncogenic Stress, and Chronic Inflammatory Responses Leading to Aging. | Cells | 2024 | https://conductscience.org/library/papers/38891017 | PubMed |
| 38665231 | Interferons and interferon-related pathways in heart disease. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38665231 | PubMed |
| 38594382 | Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage. | Commun Biol | 2024 | https://conductscience.org/library/papers/38594382 | PubMed |
| 38392865 | Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs. | Pathogens | 2024 | https://conductscience.org/library/papers/38392865 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/571963
GET https://conductscience.org/api/papers/v1/571963/cited_by?page=2